On August 31, 2026, President Donald Trump announced new agreements with nine pharmaceutical companies. These companies pledged to lower prices on certain medications. This move aligns with Trump’s Most Favored Nation program and serves as part of his administration’s broader health care agenda.

During a presentation in the Oval Office, President Trump highlighted these agreements as a critical achievement. The focus on reducing drug prices comes as part of an effort to uphold his administration’s promises regarding health care. The timing of these announcements is particularly significant with the midterm elections approaching.

President Trump emphasized that this initiative is a step towards making medications more affordable. The agreements with these pharmaceutical firms reflect a push for more competitive pricing in the industry.